eli lilly retatrutide ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Lilly announces more next-gen obesity

And they point the way to a new class of antidepressants that could be freer of side effects and faster-acting than those in use today, and that may help patients for whom existing treatments don't work or have stopped working

B12 injections are often recommended for individuals who have: - B12 Deficiency: Caused by poor absorption, certain medical conditions, or a diet low in B12

SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists Consortium

(2024, June 1)

This broader platform strategy may create additional long-term optionality and commercial flexibility as the obesity treatment market continues evolving

Cell Rep 4(3):477491